Shareholders of [Company Name] are set to vote on resolutions at an upcoming general meeting that would authorize the company’s board of directors to borrow funds and issue securities. Resolution 1 permits the board to borrow money and pledge company assets as collateral, providing financial flexibility but potentially increasing debt risk. Resolution 2 allows the company to issue new shares or other securities to raise capital, which could dilute existing shareholders’ ownership. Specific details regarding the amount of borrowing, type of securities issued, pricing, and investors have not been determined and will be decided by the board at a later date, subject to regulatory compliance. The resolutions are enabling in nature, granting the board authority to act, and promoters will not participate in any potential Qualified Institutional Placement.

Apollo Tyres Ltd. informed the Bombay Stock Exchange and National Stock Exchange of India that the trading window for securities of the company will be closed for designated persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026, in compliance with Securities and Exchange Board of India regulations.

Batliboi Limited informed the BSE Limited that the trading window for dealing in the company's shares will be closed for designated persons and their immediate relatives from Wednesday, September 30, 2026, and will remain closed until the announcement of the financial results for the quarter and half year ended September 30, 2026, with the window reopening 48 hours after the results announcement.

Bliss GVS Pharma Limited will close its trading window for insiders, designated persons, and their immediate relatives starting October 1, 2026, and continuing until 48 hours after the announcement of the company’s unaudited financial results for the quarter and half year ended September 30, 2026, as per Securities Exchange Board of India regulations.

Britannia Industries Limited announced the appointment of N. Venkataraman as Deputy Managing Director, effective October 1, 2026, while also redesignating him from Executive Director and Chief Financial Officer. Simultaneously, the company appointed Ramamurthy Jayaraman as Chief Financial Officer, also effective October 1, 2026. Venkataraman will be responsible for finance, strategy, legal, secretarial, and IT functions, working alongside Chief Executive Officer and Managing Director Rakshit Hargave, while Jayaraman will head the entire finance function.

Cosmo First Limited announced it has entered into a business transfer agreement to acquire “Prolife Speciality Vet Clinic LLP” in Mumbai on an “as is where is” basis through a slump sale, according to a regulatory filing. The acquisition will accelerate the growth of veterinary services within the company’s Petcare division, Zigly, with the target entity having a current annual run rate of Rs 4.36 crore and a turnover of Rs 0.83 crore, Rs 0.83 crore, and Rs 1.95 crore for fiscal years 2024, 2025, and 2026, respectively; the consideration is not disclosed due to confidentiality.

Fermenta Biotech Limited announced that the trading window for its securities will be closed from October 1, 2026, until 48 hours after the announcement of the company’s unaudited financial results for the quarter and half year ending September 30, 2026.